Copper and Cuproptosis: New Therapeutic Approaches for Alzheimer's Disease

Overview

Journal Front Aging Neurosci

Specialty Geriatrics

Date 2024 Jan 5

PMID 38178962

Authors

Xiao Li

Xinwang Chen

Xiyan Gao

Affiliations

Soon will be listed here.

Abstract

Copper (Cu) plays a crucial role as a trace element in various physiological processes in humans. Nonetheless, free copper ions accumulate in the brain over time, resulting in a range of pathological changes. Compelling evidence indicates that excessive free copper deposition contributes to cognitive decline in individuals with Alzheimer's disease (AD). Free copper levels in the serum and brain of AD patients are notably elevated, leading to reduced antioxidant defenses and mitochondrial dysfunction. Moreover, free copper accumulation triggers a specific form of cell death, namely copper-dependent cell death (cuproptosis). This article aimed to review the correlation between copper dysregulation and the pathogenesis of AD, along with the primary pathways regulating copper homoeostasis and copper-induced death in AD. Additionally, the efficacy and safety of natural and synthetic agents, including copper chelators, lipid peroxidation inhibitors, and antioxidants, were examined. These treatments can restore copper equilibrium and prevent copper-induced cell death in AD cases. Another aim of this review was to highlight the significance of copper dysregulation and promote the development of pharmaceutical interventions to address it.

Citing Articles

BubR1 and SIRT2: Insights into aneuploidy, aging, and cancer.

Pun R, Kumari N, Monieb R, Wagh S, North B Semin Cancer Biol. 2024; 106-107:201-216.

PMID: 39490401 PMC: 11625622. DOI: 10.1016/j.semcancer.2024.10.005.

Cuproptosis and Cu: a new paradigm in cellular death and their role in non-cancerous diseases.

Yang Z, Feng R, Zhao H Apoptosis. 2024; 29(9-10):1330-1360.

PMID: 39014119 DOI: 10.1007/s10495-024-01993-y.

Editorial Commentary: Copper Homeostasis in Neurodegenerative Diseases.

Li Y, Wang K Curr Med Sci. 2024; 44(1):244-245.

PMID: 38393531 DOI: 10.1007/s11596-024-2841-y.

References

Detampel P, Beck M, Krahenbuhl S, Huwyler J . Drug interaction potential of resveratrol. Drug Metab Rev. 2012; 44(3):253-65. DOI: 10.3109/03602532.2012.700715. View

Kano A, Watanabe Y, Takeda N, Aizawa S, Akaike T . Analysis of IFN-gamma-induced cell cycle arrest and cell death in hepatocytes. J Biochem. 1997; 121(4):677-83. DOI: 10.1093/oxfordjournals.jbchem.a021639. View

Gaier E, Eipper B, Mains R . Copper signaling in the mammalian nervous system: synaptic effects. J Neurosci Res. 2012; 91(1):2-19. PMC: 3926505. DOI: 10.1002/jnr.23143. View

Zheng Z, White C, Lee J, Peterson T, Bush A, Sun G . Altered microglial copper homeostasis in a mouse model of Alzheimer's disease. J Neurochem. 2010; 114(6):1630-8. PMC: 2945454. DOI: 10.1111/j.1471-4159.2010.06888.x. View

Lamtai M, Zghari O, Ouakki S, Marmouzi I, Mesfioui A, El Hessni A . Chronic copper exposure leads to hippocampus oxidative stress and impaired learning and memory in male and female rats. Toxicol Res. 2020; 36(4):359-366. PMC: 7494722. DOI: 10.1007/s43188-020-00043-4. View

Andersen O . Chemical and biological considerations in the treatment of metal intoxications by chelating agents. Mini Rev Med Chem. 2004; 4(1):11-21. DOI: 10.2174/1389557043487583. View

Du X, Zheng Y, Wang Z, Chen Y, Zhou R, Song G . Inhibitory act of selenoprotein P on Cu(+)/Cu(2+)-induced tau aggregation and neurotoxicity. Inorg Chem. 2014; 53(20):11221-30. DOI: 10.1021/ic501788v. View

An Y, Li S, Huang X, Chen X, Shan H, Zhang M . The Role of Copper Homeostasis in Brain Disease. Int J Mol Sci. 2022; 23(22). PMC: 9698384. DOI: 10.3390/ijms232213850. View

Esquerda-Canals G, Roda A, Marti-Clua J, Montoliu-Gaya L, Rivera-Hernandez G, Villegas S . Treatment with scFv-h3D6 Prevented Neuronal Loss and Improved Spatial Memory in Young 3xTg-AD Mice by Reducing the Intracellular Amyloid-β Burden. J Alzheimers Dis. 2019; 70(4):1069-1091. DOI: 10.3233/JAD-190484. View

10.

Squitti R, Pasqualetti P, Forno G, Moffa F, Cassetta E, Lupoi D . Excess of serum copper not related to ceruloplasmin in Alzheimer disease. Neurology. 2005; 64(6):1040-6. DOI: 10.1212/01.WNL.0000154531.79362.23. View

11.

Do Val-da Silva R, Peixoto-Santos J, Scandiuzzi R, Balista P, Bassi M, Glass M . Decreased neuron loss and memory dysfunction in pilocarpine-treated rats pre-exposed to hypoxia. Neuroscience. 2016; 332:88-100. DOI: 10.1016/j.neuroscience.2016.06.047. View

12.

James S, Volitakis I, Adlard P, Duce J, Masters C, Cherny R . Elevated labile Cu is associated with oxidative pathology in Alzheimer disease. Free Radic Biol Med. 2011; 52(2):298-302. DOI: 10.1016/j.freeradbiomed.2011.10.446. View

13.

Olas B, Wachowicz B . Resveratrol, a phenolic antioxidant with effects on blood platelet functions. Platelets. 2005; 16(5):251-60. DOI: 10.1080/09537100400020591. View

14.

Numakawa T, Suzuki S, Kumamaru E, Adachi N, Richards M, Kunugi H . BDNF function and intracellular signaling in neurons. Histol Histopathol. 2009; 25(2):237-58. DOI: 10.14670/HH-25.237. View

15.

Abbas N, Bednar I, Mix E, Marie S, Paterson D, Ljungberg A . Up-regulation of the inflammatory cytokines IFN-gamma and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APP(SWE) transgenic mice. J Neuroimmunol. 2002; 126(1-2):50-7. DOI: 10.1016/s0165-5728(02)00050-4. View

16.

Jand A, Taheri-Nejad M, Mosleh M, Palizvan M . Low, but Not High, Doses of Copper Sulfate Impair Synaptic Plasticity in the Hippocampal CA1 Region In Vivo. Biol Trace Elem Res. 2018; 185(1):143-147. DOI: 10.1007/s12011-017-1234-5. View

17.

Xiong C, Ling H, Hao Q, Zhou X . Cuproptosis: p53-regulated metabolic cell death?. Cell Death Differ. 2023; 30(4):876-884. PMC: 10070433. DOI: 10.1038/s41418-023-01125-0. View

18.

Tai H, Serrano-Pozo A, Hashimoto T, Frosch M, Spires-Jones T, Hyman B . The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. Am J Pathol. 2012; 181(4):1426-35. PMC: 3463637. DOI: 10.1016/j.ajpath.2012.06.033. View

19.

Sestito S, Wang S, Chen Q, Lu J, Bertini S, Pomelli C . Multi-targeted ChEI-copper chelating molecules as neuroprotective agents. Eur J Med Chem. 2019; 174:216-225. DOI: 10.1016/j.ejmech.2019.04.060. View

20.

Lei P, Ayton S, Bush A . The essential elements of Alzheimer's disease. J Biol Chem. 2020; 296:100105. PMC: 7948403. DOI: 10.1074/jbc.REV120.008207. View